A. Miyamoto

Bone morphogenetic protein-induced heterotopic bone formation: What have we learned from the history of a half century?

T. Katagiri, K. Osawa, S. Tsukamoto, 2015 .

Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors.

S. Ohte, T. Katagiri, K. Osawa, 2015, Molecular endocrinology.

In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid

R. Kamijo, M. Takami, A. Dezawa, 2017, Pathology & Oncology Research.

Dual usage of a stage-specific fluorescent reporter system based on a helper-dependent adenoviral vector to visualize osteogenic differentiation

H. Okano, K. Mitani, M. Nakanishi, 2019, Scientific Reports.

Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling

E. Jimi, S. Ohte, T. Katagiri, 2014, Scientific Reports.

Establishment of a novel model of chondrogenesis using murine embryonic stem cells carrying fibrodysplasia ossificans progressiva-associated mutant ALK2.

S. Ohte, T. Katagiri, K. Osawa, 2014, Biochemical and biophysical research communications.

R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts

Takako Yamada, S. Shioda, Y. Miyamoto, 2012, Cytotechnology.

Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes

E. Jimi, S. Ohte, H. Hohjoh, 2012, Journal of Bone and Mineral Metabolism.